iStock Limited’s promoter group entities Ayush Agarwal Trust and Ravi Agarwal Trust plan to together sell 4.6% stake in the drugmaker through a block deal on Thursday, according to reports.
Through the sale, the entities are looking at raising close to Rs 650 crore. The minimum price they plan to offer for the sale is Rs 1,113, a 5% discount to the current market price.
On Wednesday, shares of Ajanta Pharma ended 0.6% higher on the National Stock Exchange at Rs 1,171.80.
As of September 30, the total promoter group holding in the company stood at 70.5%. Of this, the two promoter group entities together held 28.73% stake. Jefferies has been appointed as the broker to conduct the transaction.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Through the sale, the entities are looking at raising close to Rs 650 crore. The minimum price they plan to offer for the sale is Rs 1,113, a 5% discount to the current market price.
On Wednesday, shares of Ajanta Pharma ended 0.6% higher on the National Stock Exchange at Rs 1,171.80.
As of September 30, the total promoter group holding in the company stood at 70.5%. Of this, the two promoter group entities together held 28.73% stake. Jefferies has been appointed as the broker to conduct the transaction.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.